Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol

P Alves, C Amaral, N Teixeira… - Pharmacological …, 2020 - Elsevier
Cannabis is the most used illicit drug worldwide and its medicinal use is under discussion,
being regulated in several countries. However, the psychotropic effects of Δ 9 …

The (poly) pharmacology of cannabidiol in neurological and neuropsychiatric disorders: molecular mechanisms and targets

RM Vitale, FA Iannotti, P Amodeo - International journal of molecular …, 2021 - mdpi.com
Cannabidiol (CBD), the major nonpsychoactive Cannabis constituent, has been proposed
for the treatment of a wide panel of neurological and neuropsychiatric disorders, including …

Cannabinoid treatment for autism: a proof-of-concept randomized trial

A Aran, M Harel, H Cassuto, L Polyansky, A Schnapp… - Molecular autism, 2021 - Springer
Background Endocannabinoid dysfunction in animal models of autism spectrum disorder
(ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this …

Listening to the autistic voice: Mental health priorities to guide research and practice in autism from a stakeholder-driven project

TW Benevides, SM Shore, K Palmer, P Duncan… - …, 2020 - journals.sagepub.com
Autistic adults are significantly more likely to experience co-occurring mental health
conditions such as depression and anxiety. Although intervention studies are beginning to …

Cannabinoids as medicinals

JH Khalsa, G Bunt, K Blum, SB Maggirwar… - Current addiction …, 2022 - Springer
Purpose of review There have been many debates, discussions, and published writings
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …

Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics

AK Schlag, SE O'Sullivan, RR Zafar, DJ Nutt - Neuropharmacology, 2021 - Elsevier
Abstract Knowledge about the therapeutic potential of medical cannabis has greatly
improved over the past decade, with an ever-increasing range of developments in human …

[HTML][HTML] A systematic review of cannabidiol trials in neurodevelopmental disorders

NF Parrella, AT Hill, PG Enticott, P Barhoun… - Pharmacology …, 2023 - Elsevier
Cannabis-derived compounds, such as cannabidiol (CBD) and delta-9-trans-
tetrahydrocannabinol (THC), are increasingly prescribed for a range of clinical indications …

The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)

CM Pretzsch, B Voinescu, MA Mendez… - Journal of …, 2019 - journals.sagepub.com
Background: The potential benefits of cannabis and its major non-intoxicating component
cannabidiol (CBD) are attracting attention, including as a potential treatment in …

Autism: plants with neuro-psychopharmacotherapeutic potential

M Sevindik, FS Mohammed… - Prospects in …, 2023 - prospects.wum.edu.pl
In recent years, there has been an increasing prevalence of cases of autism. There is no
general cure for autism; however, there are situational treatments available. In this context …

[HTML][HTML] Cannabis and cannabinoid use in autism spectrum disorder: a systematic review

EA Silva Junior, WMB Medeiros, N Torro… - Trends in psychiatry …, 2021 - SciELO Brasil
Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder
characterized by persistent deficits in social communication and social interaction …